Breaking News on Contract Research, Manufacturing & Clinical Trials

Patheon to manufacture amyloidosis antibody treatment for Caelum

02-Jun-2017 - Caelum Biosciences has selected Patheon to make its lead antibody CAEL-101 to treat orphan disease amyloid light-chain (AL) amyloidosis.

Cambrex continues to up capacity with more than $200m invested in 5 years

31-May-2017 - Cambrex Corporation has increased new capacity at its Sweden-based cGMP as the manufacturer focuses on market demand and customer need, says VP.

People on the move

Outsourcing-Pharma's Hiring and Firing Roundup May '17

31-May-2017 - This month’s roundup includes new executive leadership teams, hires on both sides of the Atlantic for CRO Smithers Viscient, a new VP and medical director at Clinipace, among others....

Hovione launches first clinical trial, more to come

25-May-2017 - Hovione has launched its first clinical trial and has already set sights on a second as the CDMO hopes to establish licensing partnership with pharma, says VP.

LSNE tapped for drug substance manufacturing, fill/finish services

25-May-2017 - LSNE Contract Manufacturing has signed a manufacturing supply agreement with Selecta Biosciences, Inc. through which the CDMO will advance Selecta’s lead candidate, SEL-212.

CDMO Recro expands manufacturing capabilities at former Alkermes site

24-May-2017 - Recro has added a new tablet manufacturing suite that enables it to compress single- and bi-layer tablets at commercial speeds.

CPhI North America

Cambrex invests $2.4m at former PharmaCore site

17-May-2017 - Cambrex Corporation is installing a fourth reactor suite at its High Point, NC-based facility as it continues to grow with its customers in the market, says company VP at CPhI North America....

Thermo Fisher: $7.2bn Patheon sits in sweet spot for bioproduction business

17-May-2017 - Thermo Fisher says Patheon will become the most competitive biologics CDMO in the market through direct access to its bioprocessing technologies and capabalities.

Family-owned Flamma opens $20m cGMP facility in China

16-May-2017 - Flamma has opened a new cGMP workshop and R&D Center in Dalian, China and is looking to add capacity at several other sites as part of its “Flamma 2020 plan.”...

Avantor to spend $6.4bn on VWR acquisition

12-May-2017 - Avantor has agreed to purchase independent laboratory product, supply chain and service provider VWR for approximately $6.4bn (€5.9bn), reflecting a share price of $33.25.

Aptar Pharma continues its North American expansion

11-May-2017 - Aptar Pharma has acquired 20% of the US-based company, Kali Care, less than two months after inaugurating its first facility outside of France as it aims to expand globally. 

CMO sector still set for consolidation says industry expert

11-May-2017 - Mergers and acquisitions remain a key growth strategy for contract manufacturing organizations (CMOs) as uncertainly persists across the industry. 

Brammer invests in commercial-ready gene therapies

10-May-2017 - Brammer Bio says its commercial-scale gene therapy manufacturing facility in Cambridge, Massachusetts, US, will open in the second half of 2017.

Shire using Baxalta network to bring 30% Cinryze production in-house

05-May-2017 - Shire has begun adding capability within its own network to manufacture the Hereditary Angioedema (HAE) product Cinryze, currently being made by Dutch CMO Sanquin.

BioMarin defends US FDA-approved Brineura’s $702k price tag

04-May-2017 - Brineura's $702,000 (€640,000) a-year price tag reflects production costs and investment in tech used to administer the enzyme replacement therapy to the brain says BioMarin Pharmaceuticals.

PharmaCell to make autologous cell therapies for Lion Biotech

28-Apr-2017 - Dutch contract manufacturer PharmaCell B.V has signed a three-year Manufacturing Services Agreement to make cancer cell therapies for Lion Biotechnologies.

Recipharm invests $750k in new GMP suite

27-Apr-2017 - Recipharm has opened a new GMP suite for clinical trial material manufacture at its North Carolina-based facility in Research Triangle Park.

Solubility solutions: Catalent increases spray drying capacity at Pharmatek

27-Apr-2017 - Catalent Pharma Solutions is increasing cGMP spray drying capacity at its Pharmatek facility in response to industry demand for improved solubility.

EAG expanding bioassay lab, adding new staff

26-Apr-2017 - EAG Laboratories is expanding its Columbia, Missouri-based cell bioassay laboratory to support multiple development programs.

DSM Sinochem to up capacity at Delft antibiotic intermediates plant

24-Apr-2017 - DSM Sinochem (DSP) has announced its intention to increase antibiotic production capacity at its facility in Delft, the Netherlands.

IriSys clinical trial material manufacturing contract upped to $6m

24-Apr-2017 - IriSys LLC has been awarded an increase to its five-year prime vendor contract – an agreement now worth up to $6m.

Wearable drug delivery tech firm Unilife files for Chapter 11 bankruptcy

20-Apr-2017 - Unilife Corporation has filed for Chapter 11 bankruptcy and confirmed that a key customer for its wearable injectors business has halted a project.

Plasticell secures funding for red blood cell substitute development

19-Apr-2017 - Plasticell is advancing multiple projects through which it will develop and manufacture red blood cell substitutes for human clinical transfusion and progress preclinical trials.

News in brief

ABL to fill live virus-based MCMs for BARDA

10-Apr-2017 - ABL, Inc. will provide fill/finish services for live virus-based medical countermeasures (MCM) as part of the five-year contract worth up to $50m.

US FDA hits Indoco with warning due to leaky glaucoma drug

05-Apr-2017 - Leakage problems for of an ophthalmic drug has landed contract manufacturer Indoco Remedies with a US FDA warning letter at its plant in Goa.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...